GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

In its order, CJ Upadhyaya-led bench directed PIL litigant to submit to CDSCO the scientific studies and data relied upon in ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Ecnoglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist analogue, similar to the blockbuster obesity drug semaglutide. These drugs mimic the hormone GLP-1, which is involved in regulating ...